Publikationen (77) Publikationen von Paula Ortega Lopez

2024

  1. A new class of polyphenolic carbosilane dendrimers binds human serum albumin in a structure-dependent fashion

    Scientific Reports, Vol. 14, Núm. 1

  2. Actualización del Manejo de la Eclampsia ¿Que ha Cambiado?

    Ciencia Latina: Revista Multidisciplinar, Vol. 8, Núm. 3, pp. 365-377

  3. Effect of polyphenolic dendrimers on biological and artificial lipid membranes

    Chemistry and Physics of Lipids, Vol. 265

  4. Medidas Preventivas en el Embarazo para Disminuir la Incidencia de la Asfixia Perinatal

    Ciencia Latina: Revista Multidisciplinar, Vol. 8, Núm. 4, pp. 3553-3564

  5. Polyphenolic dendrimers as carriers of anticancer siRNA

    International Journal of Pharmaceutics, Vol. 658

  6. Targetable domains for the design of peptide-dendrimer inhibitors of SARS-CoV-2

    International Journal of Pharmaceutics, Vol. 661

  7. The repertoire of iron superoxide dismutases from Leishmania infantum as targets in the search for therapeutic agents against leishmaniasis

    Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 39, Núm. 1

2023

  1. Carbosilane dendritic nanostructures, highly versatile platforms for pharmaceutical applications

    Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, Vol. 15, Núm. 3

  2. Carbosilane ruthenium metallodendrimer as alternative anti-cancer drug carrier in triple negative breast cancer mouse model: A preliminary study

    International Journal of Pharmaceutics, Vol. 636

  3. Combination of Copper Metallodendrimers with Conventional Antitumor Drugs to Combat Cancer in In Vitro Models

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

  4. Lipid-coated ruthenium dendrimer conjugated with doxorubicin in anti-cancer drug delivery: Introducing protocols

    Colloids and Surfaces B: Biointerfaces, Vol. 227

  5. Ruthenium metallodendrimer against triple-negative breast cancer in mice

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 53

2022

  1. Amoebicidal activity of cationic carbosilane dendrons derived with 4-phenylbutyric acid against Acanthamoeba griffini and Acanthamoeba polyphaga trophozoites and cysts

    Scientific Reports, Vol. 12, Núm. 1

  2. Dendrimers and Dendritic Materials against Infectious Diseases

    Pharmaceutics

  3. Heterofunctional carbosilane polyphenolic dendrons: new antioxidants platforms

    RSC Advances, Vol. 12, Núm. 17, pp. 10280-10288

  4. Heterofunctionalized polyphenolic dendrimers decorated with caffeic acid: Synthesis, characterization and antioxidant activity

    Sustainable Materials and Technologies, Vol. 33

  5. Inhibition of Candida glabrata Biofilm by Combined Effect of Dendritic Compounds and Amphotericin

    Pharmaceutics, Vol. 14, Núm. 8

2021

  1. Cationic Carbosilane Dendrimers Prevent Abnormal α-Synuclein Accumulation in Parkinson's Disease Patient-Specific Dopamine Neurons

    Biomacromolecules, Vol. 22, Núm. 11, pp. 4582-4591

  2. Combined therapy of ruthenium dendrimers and anti-cancer drugs against human leukemic cells

    Dalton Transactions, Vol. 50, Núm. 27, pp. 9500-9511

  3. Effect of the combination of levofloxacin with cationic carbosilane dendron and peptide in the prevention and treatment of staphylococcus aureus biofilms

    Polymers, Vol. 13, Núm. 13